Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Testing
Animal Alternatives
Efficacy
Method/Process
Microbiology
Saftey/Stability
Sensory
Sun Protection
Tech/Equipment/Services
Safety/Stability
SPF/Sun
Safety Alert: Sunscreen 'Doping' and Foam Formats Raise Red Flags
Recent regulatory attention highlights both hidden sunscreen actives in cosmetic products, and the legal gray zone of mousse-format sunscreens — prompting calls for clearer labeling and format approval.
Event Coverage
Testing Innovators: Submit Now to Take Center Stage at the
2026 C&T Allē Awards
Polls
Poll Results: What is Your Biggest Concern Regarding Consumer Safety in Cosmetics?
Latest
Safety
[podcast] How to Meet MoCRA's Safety Testing Mandates
In this podcast, Lenore Coyle, president of Eurofins, shares insights on the challenges of MoCRA testing mandates. She provides tips on ways to prepare, and highlights Eurofins' services that support these efforts. Register now to listen and learn more.
Safety
7 Recent Recalls: Babygenics, Tom's of Maine, Amika, HiBAR and Others
From hair spray and repair cream, to tattoo ink, children's sunscreen, toothpaste and others, several products have been recalled in recent months due to safety hazards and regulatory non-compliance. Following is an overview.
Sponsored
Remastered Fragments™: Smart, Ethical Innovation in Skincare
Fragments remastered™ fuses biotech and sustainability to deliver biomimetic protein fragments via vertical farming. These actives boost collagen, elasticity, and skin structure—clinically proven, ethical, and eco-conscious skincare innovation.
Polls
[poll results] How Do You Usually Assess Product Shelf Life?
We noted last week that per the FDA, there are currently no U.S. regulations that require cosmetics to have certain shelf lives -- but manufacturers must ensure that products are safe. So we asked: How do you assess shelf life? Here's what you said.
Safety
FDA Proposes MoCRA-mandated Tests to Detect Asbestos in Talc-containing Cosmetics
On Dec. 26, 2024, the FDA proposed test methods by which cosmetic manufacturers would be required by MoCRA to assess talc-containing products for asbestos, along with enforcement provisions.
Safety
Safety Alerts: Drunk Elephant's 'Mix-up,' 285 European Cosmetics with Banned Ingredients, Dynarex Extended Recall
This round-up highlights recent cosmetic safety alerts/recalls. These include: Drunk Elephant's ingredient "mix-up," ECHA's findings that 6% of ~4,500 cosmetics reviewed contained banned ingredients, and Dynarex's recall extension over possible asbestos.
Event Coverage
How Dynamic Streaming Potential Can Take Formulation Science to the Next Level — Free Webcast
Analyzing the physico-chemical properties of formulas helps to optimize them so they ultimately deliver on consumer expectations. Dynamic streaming potential takes this to a new level, as a free webcast from Anton Paar explains. Register now.
Polls
[poll results] What is Your Preferred Method of Product Stability Testing?
There are a number of ways to measure the stability of formulas. Last week, we asked which is your favorite way: Real-time, accelerated or both? Here's how you responded.
Safety
J&J Talc Suit Tally: $6.48 B Offer, $11 B Reserves, $700 M to States — Plus New Class Action and Talc-Cancer Evidence
J&J's path through talc suits is long, winding and confusing. Here, we've mapped out payouts and recent twists and turns — including a new class action seeking damages and medical monitoring, and a recent study suggesting a talc-cancer association.
SPF/Sun
[update] How ISO's Endorsement of Two Test Methods Will Enlighten Sunscreen Development
After 10 years, sunscreen developers are nearing the finish line for more ethical, cost efficient, reliable and faster testing thanks to ISO's endorsement of two standards. The final vote was in September 2024. Here, two experts explain what this means.
Safety
J&J Proposes $6.475 B Plan to Settle Ovarian Cancer Talc Claims
The settlement would be paid over 25 years, and per the company, is a better offer than the claimants stand to recover at trial. Indeed, the scientific testimony linking ovarian cancer to J&J's products is being re-reviewed, posing the risk of dismissal.